Scaling Global Visibility: Comprehensive Healthcare Systems Partners with RedChip to Fuel Investor Growth
The landscape of healthcare benefits administration is undergoing a massive digital shift, and Comprehensive Healthcare Systems Inc. (OTCQB: CMHSF) is positioning itself at the very forefront of this transformation. In a strategic move designed to bridge the gap between its technical milestones and market recognition, CHS has officially announced the engagement of RedChip Companies to spearhead its investor relations and strategic communications efforts. This partnership marks a significant chapter for CHS as it seeks to translate its operational successes into a broader narrative for the global investment community.
A Pivotal Moment for CHS
Timing is everything in the world of high-growth SaaS. According to Chris Cosgrove, CEO of Comprehensive Healthcare Systems, the company has reached what he describes as a "pivotal point" in its evolution. This isn't just about growth for the sake of growth; it’s about a company that has matured into its potential. With a string of recent client wins and the achievement of positive adjusted EBITDA, CHS is no longer just a promising startup in the HealthTech space—it is a proven operator with a sustainable financial trajectory.
By partnering with RedChip, CHS aims to amplify this story. RedChip is well-regarded for its ability to connect innovative companies with both institutional and retail investors. For CHS, the goal is clear: ensure that the strategy, execution, and long-term value proposition of the company are effectively articulated to those who can help fuel its next stage of expansion.
The Novus 360 Edge: More Than Just Software
At the heart of the CHS value proposition is the Novus 360 Healthcare Welfare and Benefits Administration (HWBA) SaaS platform. In an era where self-funded employers, third-party administrators (TPAs), and hospitals are struggling with rising costs and administrative complexity, Novus 360 provides a much-needed breath of fresh air. The platform is designed to drive automation and transparency while ensuring strict compliance and cost containment.
Recent enhancements to the platform have focused heavily on AI-driven capabilities. These updates are specifically tailored to meet the needs of a diverse range of clients, including pension funds and multi-employer unions across North America. By digitizing what were once manual and error-prone processes, CHS is not only improving efficiency but also establishing itself as a vital infrastructure provider for the modern healthcare economy.
RedChip’s Strategic Role in the Expansion
Dave Gentry, CEO of RedChip, expressed a strong conviction in the CHS investment thesis. He noted that the company has built a highly scalable platform that addresses a significantly underserved segment of the market. From RedChip’s perspective, the combination of a growing enterprise client base and the transition to profitability makes CHS a compelling story for investors who are looking for HealthTech leaders with actual bottom-line results.
Less busywork, more real work.
We build robust internal tools and scalable SaaS platforms so your team can stop drowning in spreadsheets and start focusing on growth.
RedChip will deploy its integrated investor relations, media, and digital distribution platforms to communicate CHS’s progress. This isn't just about traditional press releases; it’s about a multi-channel approach that includes national media and TV ad campaigns. In fact, part of the agreement includes a dedicated two-week national media blitz scheduled for the first quarter of 2026, aimed at putting CHS directly in front of a massive audience.
Breaking Down the Partnership Details
The engagement, which began on January 9, 2026, involves a structured compensation package reflecting a long-term commitment. RedChip will receive a monthly fee of US$7,500, along with 150,000 stock options. These options are exercisable at C$0.60 per share over a five-year period, with vesting occurring quarterly over six months. This structure aligns RedChip’s incentives with the long-term performance of CHS stock, signaling confidence in the company's future valuation.
Furthermore, the one-time US$60,000 fee for the Q1 2026 media campaign highlights CHS's readiness to invest in its brand. As the company continues to secure multi-year enterprise agreements and strengthen its balance sheet, the focus now shifts to ensuring the market understands the depth and scale of what CHS is building. For investors and stakeholders, this partnership with RedChip is a clear signal that Comprehensive Healthcare Systems is ready for the spotlight.